In 2002, in the heart of a quiet but bustling island, the foundation stone of Kish Medipharm Pharmaceutical Group was laid. A bold and forward-looking idea that from the very beginning looked beyond the boundaries of mere production. A view that defined human health not as a target market, but as a human, scientific, and ethical responsibility.
The initial steps of this path, although accompanied by technical and structural limitations, quickly turned into a purposeful and coherent movement, backed by faith and expertise. Now that 24 years have passed since those early days, Kish Medipharm has not only reached industrial maturity, but has also become a model for social responsibility in the country's pharmaceutical industry.
Medipharm's Mission: Helping Humanity, Not Just Healing
In a world where competition sometimes marginalizes ethics, Medipharm's creed is built on a foundation that places humans at the center of decision-making. Our mission is not to cure; it is to create dignity. Medicine is a means, not an end.
Kish Medipharm Pharmaceutical Group has always strived to go beyond traditional prescription by accurately understanding the medical and psychological needs of patients. The production of a pharmaceutical product is valuable when it leads to lasting peace in an individual's life. Therefore, we believe in not only treating diseases, but also in healing human concerns.
A look at Kish Medipharm's achievements: From a small island to a global horizon
Over the past two decades, Kish Medipharm has overcome infrastructural and competitive challenges and is now in a position from which international horizons can be clearly seen. This complex now has a significant share in the country's pharmaceutical market by producing over 240 pharmaceutical products, both under its own brand and in the form of contract manufacturing for other companies.
The diversity of products, from topical medications and supplements to recombinant products and advanced anti-inflammatories, demonstrates that a research-oriented approach has always been at the heart of this organization. Entering the fields of biopharma and biotechnology is a sign of boldness and foresight in developing the product portfolio.
Why is this anniversary of the founding of Medipharm important to us?
Anniversaries are not just a passing stop on the calendar. They are moments that bring the past, present, and future to life in a single frame, in our minds and hearts. 24 years ago, Medipharm Kish was born with a committed vision. Today, this vision has become a framework of shared beliefs.
On this day, we not only review history, but also illuminate the path to the future. This celebration is an opportunity to acknowledge every hand that has played a role in creating this path: from the assembly line worker to the CEO, from the pharmacist to the researcher.
Speeches by the CEO of Kish Medipharm Pharmaceutical Group and the founder of this group on the 24th anniversary of its establishment
On the eve of the 24th anniversary of the founding of Kish Medipharm Pharmaceutical Group, we have a great opportunity to take a deeper look at the company's tumultuous path; a path that has been shaped by determination, idealism, and commitment to the health of society. In this regard, the CEO and founder of this group, in a speech, explained the various dimensions of this meaningful journey.
Referring to the circumstances of the company's formation, CEO Dr. Majid Mohammad Hosseini spoke of the years when the country's pharmaceutical industry needed institutions that were not only responsive to demand, but also innovative in providing solutions.
He added: "The Medipharm cult was born not out of prosperity, but out of need. We began our activities in a time when shortages, import problems, and the lack of stable infrastructure made every step a difficult test."
The effort to overcome these bottlenecks was not simply an economic move; a kind of national mission lay at its heart.
Loyalty to quality: the fundamental pillar in every stage of Kish Medipharm's activity
Dr. Majid Mohammad Hosseini, founder and CEO of Kish Medipharm Pharmaceutical Company, continued: "From the first day, our philosophy was not to produce or offer a product that would simply make it to the market; rather, it had to pass ethical, scientific, and professional tests." He emphasized that maintaining international standards in the production and import of drugs has been one of the inviolable principles of this company. Even in difficult economic conditions, Kish Medipharm did not sacrifice quality for short-term profit.
One of the focuses of the founder's speech was paying attention to innovation in the pharmaceutical industry.
He noted: "Kish Medipharm has never been a mere imitator. We have considered ourselves obliged to expand the boundaries of pharmaceutical knowledge; whether through the localization of new technologies, or through research and development based on the real needs of Iranian society. Research and development in this complex is the beating heart that ensures future-oriented survival."
Dr. Mohammad Hosseini continued by pointing out the importance of the role of human resources in the sustainability of the organization: "We have never seen the company as just a collection of legal documents and physical assets. For us, Kish Medipharm has always been the result of the thoughts, efforts, and sincerity of people who have joined this path with the belief in a higher goal. Training specialized personnel, continuously improving the knowledge of employees, and promoting a responsible organizational culture have all been the pillars of the dynamism of this institution."
He also dedicated part of his speech to the role of Kish Medipharm Pharmaceutical Group in supporting the country's health system and said that for us, serving the community does not only go through the path of selling medicines. We consider ourselves part of the health ecosystem. Therefore, we have had a serious and effective presence in public benefit projects, public education, and supporting academic research. Social commitment, in this complex, has not been a slogan, but a strategic principle in macro-policymaking.
Stepping into Tomorrow: A Bright Perspective in the Shadow of Past Experiences
In the end, theDr. Majid Mohammad Hosseini Looking forward to the future, he noted: “Twenty-four years is neither the end of the road nor just a number. For us, this anniversary is an opportunity to rethink, rebuild, and reinvent. We believe in a bright future; a future in which Medipharm will play a leading role in the regional pharmaceutical industry.” He emphasized that future projects, including the development of the domestic supply chain, exports to neighboring countries, and synergies with international scientific centers, are on the agenda.
In light of these words, it becomes clear that Kish Medipharm is not just a pharmaceutical company, but a symbol of sustainability, authenticity, and commitment to health. Twenty-four years have passed since the beginning of a path, each step of which has been taken with a responsible outlook. This path continues; challenging, but glorious.
Future Outlook: New Frontiers to Far Horizons for Kish Medipharm Pharmaceutical Group
In the modern world, pharmaceuticals are not limited to manufacturing; they are also linked to data science, bioinformatics, and personalized medicine. Kish Medipharm has prepared itself for a strategic leap by properly understanding this global trend.
From expanding export capacities and entering the Middle East and Asian markets, to strengthening R&D infrastructure and entering RNA-based drugs and monoclonal antibodies, the future vision is as vast as science and humanity. From a quiet but bold island in southern Iran; where hope was born. We have reached a point where our voices echo in doctors' prescriptions and families' peace.
Kish Medipharm turns 24 today, but its values are still fresh:
Human-centeredness, scientific integrity, and an unconditional commitment to health.
